
---
title: '天药股份：醋酸地塞米松片通过仿制药一致性评价'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=4503'
author: 证券时报网
comments: false
date: Mon, 11 Jul 2022 15:53:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=4503'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600488" style="color: #2f67d1;text-decoration: none;" code="600488" target="_blank">天药股份</a>(600488)7月11日晚间公告，公司药品醋酸地塞米松片通过仿制药一致性评价。醋酸地塞米松片主要用于过敏性与自身免疫性炎症性疾病。</p>

                  
</div>
            